Skip to main content
Clinical Trials/ACTRN12615000667516
ACTRN12615000667516
Completed
Phase 3

Randomised controlled trial of tissue adhesive, integrated securement products or external stabilisation devices versus standard care (bordered polyurethane) dressings to prevent central venous access device failure in intensive care patients with non-tunnelled, percutaneous central venous access devices: the CASCADE ICU trial

Associate Professor Marion Mitchell0 sites120 target enrollmentJune 26, 2015

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Central venous access device failure prior to completion of therapy
Sponsor
Associate Professor Marion Mitchell
Enrollment
120
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Associate Professor Marion Mitchell

Eligibility Criteria

Inclusion Criteria

  • 1\. Informed written consent
  • 2\. Non\-tunnelled percutaneous CVAD to be inserted in ICU for clinical care for \>24 hours

Exclusion Criteria

  • 1\. Peripherally inserted, tunnelled, dialysis, or pulmonary artery catheters;
  • 2\. Current bloodstream infection;
  • 3\. CVAD to be inserted through diseased, burned, scarred or hirsute skin;
  • 4\. Allergy to any study product;
  • 5\. Previous study enrolment in this admission

Outcomes

Primary Outcomes

Not specified

Similar Trials